Vanderbilt: Gene Variant and Glucose Metabolism
February 19, 2021
February 19, 2021
NASHVILLE, Tennessee, Feb. 19 (TNSJou) -- Vanderbilt University issued the following news:
GLP-1 (glucagon-like peptide-1) increases glucose-mediated insulin secretion. GLP-1 receptor agonists and DPP-4 inhibitors, which prevent GLP-1 inactivation, are widely used to treat type 2 diabetes mellitus.
Mona Mashayekhi, MD, PhD, and colleagues explored whether a particular genetic variant in the GLP-1 receptor gene affected the metabolic response to a meal and to DPP-4 inhib . . .
GLP-1 (glucagon-like peptide-1) increases glucose-mediated insulin secretion. GLP-1 receptor agonists and DPP-4 inhibitors, which prevent GLP-1 inactivation, are widely used to treat type 2 diabetes mellitus.
Mona Mashayekhi, MD, PhD, and colleagues explored whether a particular genetic variant in the GLP-1 receptor gene affected the metabolic response to a meal and to DPP-4 inhib . . .